openPR Logo
Press release

Pertussis (Whooping Cough) - Pipeline Review, Industry Analysis, Trends, and Forecast Report 2017

06-30-2017 08:52 AM CET | Health & Medicine

Press release from: Business Insights Report - MRH

Business Insights Report

Business Insights Report

Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Pertussis (Whooping Cough) - Pipeline Review, H1 2017” to its report offerings. The report covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1196653

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pertussis (Whooping Cough) - Pipeline Review, H1 2017, provides an overview of the Pertussis (Whooping Cough) (Infectious Disease) pipeline landscape.

Pertussis, also known as whooping cough, is a highly contagious respiratory disease. It is caused by the bacterium Bordetella pertussis. Symptoms include runny nose, nasal congestion, sneezing, red, watery eyes and dry cough. Treatment includes antibiotics.

Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Pertussis (Whooping Cough) - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Pertussis (Whooping Cough) (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Pertussis (Whooping Cough) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pertussis (Whooping Cough) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 1, 8, 5, 6, 1, 8 and 1 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 1, 1, 1 and 3 molecules, respectively.

Pertussis (Whooping Cough) (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Pertussis (Whooping Cough) (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Pertussis (Whooping Cough) (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Pertussis (Whooping Cough) (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Pertussis (Whooping Cough) (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Pertussis (Whooping Cough) (Infectious Disease)

Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Pertussis (Whooping Cough) (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Pertussis (Whooping Cough) (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Read Full Report with TOC: http://www.marketresearchhub.com/report/pertussis-whooping-cough-pipeline-review-h1-2017-report.html

Table of Contents:
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Pertussis (Whooping Cough) - Overview
Pertussis (Whooping Cough) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Pertussis (Whooping Cough) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Pertussis (Whooping Cough) - Companies Involved in Therapeutics Development
Beijing Minhai Biotechnology Co Ltd
Bharat Biotech International Ltd
Biological E Ltd
Boryung Pharmaceutical Co Ltd
Daiichi Sankyo Company Ltd

Make an Enquiry: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1196653

About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Read Industry News @ https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pertussis (Whooping Cough) - Pipeline Review, Industry Analysis, Trends, and Forecast Report 2017 here

News-ID: 603139 • Views: 177

More Releases from Business Insights Report - MRH

Global Outdoor Cabinet Heat Exchange Equipments Market Research and Forecast Rep …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Global Outdoor Cabinet Heat Exchange Equipments Market Research Report 2017” to its report offerings. The report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Outdoor Cabinet Heat Exchange Equipments in these regions, from 2012 to 2022 (forecast). Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1220159 The global Outdoor Cabinet Heat Exchange
Global Nichrome Film Resistor Market - Industry Analysis, Growth, Trends, and Fo …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Global Nichrome Film Resistor Market Research Report 2017” to its report offerings. The report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Nichrome Film Resistor in these regions, from 2012 to 2022 (forecast). Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1220152 The global Nichrome Film Resistor market is valued at USD
Global Embolization Devices Market - Industry Analysis, Growth, Trends, and Fore …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Global Embolization Devices Market Research Report 2017” to its report offerings. The report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Embolization Devices in these regions, from 2012 to 2022 (forecast). Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1217154 The global Embolization Devices market is valued at USD XX million in
Global Duck Meats Industry Analysis, Size, Share, Growth, Trends, and Forecast R …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Global Duck Meats Market Research Report 2017” to its report offerings. The report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Duck Meats in these regions, from 2012 to 2022 (forecast). Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1217153 The report is segmented into several key Regions, with production, consumption, revenue

All 5 Releases


More Releases for Pertussis

Pertussis Vaccine Market Comprehensive Analysis and Future Estimations 2024
Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free
Growth in Adoption of Pertussis Vaccination and Government Insurance are Project …
Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free
Pertussis Vaccine Market Global Industry Volume By Region 2016 - 2024
Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free
Global Pertussis Vaccine Consumption 2016 Market Research Report
The Global Pertussis Vaccine Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Pertussis Vaccine market. First, the report provides a basic overview of the Pertussis Vaccine industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Pertussis Vaccine market size (volume and value),
Pertussis Vaccine Market: Estimated to Flourish by 2016 - 2024
The Pertussis Vaccine Market report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. Geographically, the pertussis vaccine market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the pertussis vaccine market due to growth in number of geriatric population and increase in pertussis death rate in the U.S,
Pertussis Vaccine Industry 2024 Market Research Report
Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free